SPEAKERS

Your Expert Speakers: Drug Developers, Academics & Associations

Alan Wookey

VP, Companion Diagnostics & Oncology

Q² Solutions

Amit Jain

Vice President, Commercial Strategy & Market Access

Veranex

Amy Wehn

Senior Principal Scientist (Director), Companion Diagnostics

Merck

Andy Beck

Chief Executive Officer

PathAI

Antonio Chambers

Associate Director, Technical Diagnostic Testing Services

Eli Lilly and Company

Avneet Heer

Senior Manager, Commercial Strategy & Market Access

Veranex

Benjamin Chen

Senior Director, Lab Head for Solid Tumor Translational Medicine Research

Bristol Myers Squibb

Bernard F. Andruss

Head of Companion Diagnostics

Bio-Techne, Inc

Beth Mechling

Chief Operating Officer

Kartos Therapeutics, Inc

Brian Baker

Senior Director, Regulatory Affairs (CDx)

Regeneron

Brian Tunquist

Director of Diagnostics

Pfizer

Carly Campbell

Senior Scientist, Translational Science and Diagnostics

Bicycle Therapeutics

Charo Garrido

Director

Daiichi Sankyo

Chris Capuano

Senior Director, Global Market Access, Oncology

Sanofi

Christine Martersteck

Manager Diagnostic Development

Loxo Oncology at Lilly

Colin Weller

VP Partner Technologies

Medable, Inc.

Courtney Nicholson

Senior Director of Business Development

Abcam

Dana Dilbeck

Senior Director, Market Access, Reimbursement and Pricing

Agilent

David Schlesinger

Senior Clinical Application Product Manager

SOPHiA GENETICS

Deepti Aurora-Garg

Executive Director, Companion Diagnostics | Vice President Companion Diagnostics

Merck | Prometheus Biosciences

Dr Alison Finall

Consultant Histopathologist

Swansea Bay University Health Board

Dr. Clara Monatagut

Head of Gastrointestinal Cancer

Hospital del Mar - Parc de Salut Mar

Dr. Jacob Berchuck

Instructor in Medicine

Dana-Farber Cancer Institute

Dr. Jeffrey Thompson MD, MTR

Assistant Professor of Medicine

University of Pennsylvania

Dr. Naureen Starling

Consultant Medical Oncologist

The Royal Marsden NHS Foundation Trust

Dr. Seth Wander

Assistant Professor of Medicine

Harvard Medical School

Dun Liang

Director, Regulatory Affairs, CDx

Loxo Oncology at Lilly

Dylan Marchione PhD

IDH Heme Biomarker Lead

Servier Pharmaceuticals

Eric Miller

Global Technical Specialist, CosMx SMI

NanoString Technologies

Espy Anguiano

Scientific Market Development, BioPharma

NanoString Technologies

Geoff Oxnard, MD

VP, Head of Clinical Development

Foundation Medicine

Gillian Livock

SVP & GM Digital Measures

Medable, Inc

Giulia Fabbri

Senior Director, Translational Medicine Oncology Strategy

AstraZeneca

Gulzar Sandhu

Chief Business Officer, Companion Diagnostics

Agilent Technologies

Guy Afseth

Assistant Vice President - North America

MiRXES Corporation

Heather Cohen

Director, Translational Sciences and Diagnostics

Bicycle Therapeutics

Hilary Gee Goeckner

Senior State and Local Campaigns Manager, Access to Care

American Cancer Society Cancer Action Network

Ian Kavanagh

Chief Operating Officer & Co-Founder

Apis Assay Technologies Ltd.

Jad Walters

Head of US IVD Development & Validation Almac Diagnostic Services

Almac Diagnostic Services

James Hewitt

IVD Product Expert

TÜV SÜD

Jason Baum

Vice President, Translational Medicine

Leap Therapeutics

Javier Perez

Director, Precision Medicine, Companion Diagnostics

Regeneron

Jena Giltnane

Research Director of Digital & Spatial Pathology

Genentech

Jennifer Veneris

Senior Medical Director

GSK

Jess Lambe

Director, business development, CDx partnering

illumina

Jess Riley

Chief Business Officer

Aignostics

Jie Cheng

Senior Director, Statistical and Quantitative Sciences

Takeda Pharmaceutical Company

Jim Davison

Senior Translational Genomic Scientist

Genecentric

Joe Zhou

Director of Clinical Biomarkers & Companion Diagnostics, Translational Sciences

Ultragenyx

John Simmons

Global Vice President of Biopharma

Natera

John Yi

Senior Director, Translational Medicine

G1 Therapeutics

Joshua Rusbuldt

Scientist, Oncology Translational Research, Immuno-Oncology

Janssen

Justin Odegaard

Vice President, Clinical Development

Guardant Health

Kaska Kowanetz

Director, Global Regulatory Lead

Pfizer

Keith Wharton

Vice President, Medical Director

Ultivue

Kristin Price

Product Director

Guardant Health

Lakshman Ramamurthy

Head of Global Regulatory Affairs, Precision Medicine & Digital Health

GlaxoSmithKline

Lauren Silvis

Senior Vice President of External Affairs

Tempus Labs, Inc

Lindsay Darling

Associate Director, Companion Diagnostics Portfolio Management & Operations

Regeneron

Lorry Weaver MT(ASCP), CLS

Principal Consultant

QServe Group US, Inc.

Luca Quagliata

Vice President, Global Head of Medical Affairs

Thermo Fisher Scientific

Lynn Replogle

Senior Director, Precision Medicine

Veranex

Mark Kiel

Chief Scientific Officer

Genomenon

Mark Landers

Vice President of BioPharma Partnerships

Exact Sciences

Mark Roberts, PhD

Senior Director, Diagnostic Development Services

Labcorp Drug Development

Mary Thanh Hai

Deputy Director for Clinical, Office of New Drugs

U.S. Food and Drug Administration

Matthew Beer

Head of NA Medical Affairs, Clinical Next-Generation Sequencing and Oncology

Thermo Fisher Scientific

Matthew Pink

Senior Director, Head of Business Development

Biodesix

Maureen Lane

Vice President, Clinical Science

Curis Inc.

Megan Townsend

Manager, business development, CDx partnering

illumina

Meijuan Li

Vice President, Head of Biostatistics, Oncology Group

Eisai

Melinda Day

Associate Director, Translational Clinical Development

Kronos Bio

Michael Lahn

Chief Executive Officer

iOnctura

Michael Rivers

Vice President and Lifecycle Leader, Digital Pathology

Roche Tissue Diagnostics

Michael Steele

Vice President, Business Development Pharma Partnering

Biocartis

Mikhail Roshal

Hematopathologist

Memorial Sloan Kettering Cancer Center

Minakshi Guha

LBx Strategy Lead, Companion Diagnostics

Takeda Pharmaceuticals Inc

Minghao Song

Director, Precision Medicine Lead

AstraZeneca

Naouel El Asri

Senior Director, Pharma Services

Veracyte

Neeraj Adya

Head of CDx

Genmab

Nick Gallerani

Senior Business Development Associate

NuProbe

Niv Mastboim

Head of Product Innovation

SightDx

Pahini Pandya

Co Founder, Chief Executive Officer

Panakeia Technologies

Pamela Ebrahimi

Deputy Branch Chief, Molecular Genetics Branch

CDRH, U.S. Food and Drug Administration

Partha Das

GMD Precision Medicine and Pipeline

The Janssen Pharmaceutical Companies of Johnson & Johnson

Philippe Mourere

President and CEO

Stilla Technologies

Qi Tang

Director, Digital & Data Sciences

Sanofi

Qing Li, MD, PhD

Head of Clinical Biomarker & CDx Strategy

H3 Biomedicine

Rachel Skelton, PhD

Senior Director Pharma Partnerships

Leica Biosystems

Rebecca Ann Previs

Director of Medical Affairs, Labcorp Oncology & Adjunct Faculty, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology

Duke University

Russell Garlick

Chief Scientific Officer

LGC Clinical Diagnostics

Sam Hong

Director, Global Health Economics and Outcomes Research

Agilent

Sarah Hersey

Vice President, Precision Medicine

Bristol Myers Squibb

Satya Saxena

Director, Global Proteomics, Clinical Pharmacology and Translational Medicine, Neurology Business Group

Eisai

Scott Bornheimer, PhD

Associate Director, Biomarkers & CDx, Medical & Scientific Affairs

BD Biosciences

Scott Reid

Vice President, Alliances & Companion Diagnostics

NeoGenomics

Shirin Khambata Ford

Vice President, Head Companion Diagnostics, Global Companion Diagnostics, Global Oncology R&D

Daiichi Sankyo

Si Tuen-Lee Hoeflich

Senior Director, Translational Science

Scholar Rock

Sid Mathur

Regulatory Affairs Executive Director, Companion Diagnostics

Merck

Silva Krause

Senior Director, Clinical Biomarkers

Vertex Pharmaceuticals

Srinivas Venkatram

Director, CDx Strategy

AbbVie

Stephen J Blakemore

VP, Biological & Translational Sciences

Accent Therapeutics, Inc.

Steve Anderson

Consultant

Precision Medicine & Oncology

Susanne Munksted

Chief Precision Medicine Officer

Diaceutics Plc

Susanne Rhoades

Senior Director, Diagnostic Development

Loxo Oncology at Lilly

Tiffany Patrick

Vice President, Patient Advocacy & Engagement

Alnylam Pharmaceuticals

Tony Grover

Global Director Biomarkers & CDx

BD Biosciences

Victoria Rimkunas

Senior Director, Head of Translational Medicine

Repare Therapeutics

Vijay Walia

Senior Program Director, Companion Diagnostics

Quest Diagnostics

Vladislav Chizhevsky

Medical Director

NeoGenomics

Wen-Chi Chou

Prinical Computational Biologist, Clinical Development Predictive Sciences (Oncology)

Bristol Myers Squibb

Wenora Johnson

Research & Patient Advocate

Will Howat

Senior Director of Validation and Technical Quality

Abcam

Xinru Mao

Senior Director & Pharmaceutical Biomarker Development

Burning Rock Dx

Zhen Su

Chief Executive Officer

Marengo Therapeutics